{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:27:13Z","timestamp":1793924833453,"version":"4.8.0"},"reference-count":122,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jceh.2026.103564","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T23:22:23Z","timestamp":1779232943000},"page":"103564","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Overlap Syndromes and Associated Immunoglobulin-G4-Related Liver Diseases"],"prefix":"10.1016","volume":"16","author":[{"given":"Sayan","family":"Malakar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5000-397X","authenticated-orcid":false,"given":"Sanjit","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akash","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9626-5243","authenticated-orcid":false,"given":"Suprabhat","family":"Giri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumit","family":"Rungta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7895-3440","authenticated-orcid":false,"given":"Mayank","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandeep","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4380-6058","authenticated-orcid":false,"given":"Nitesh","family":"Bassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1768-0263","authenticated-orcid":false,"given":"Arghya","family":"Samanta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uday C.","family":"Ghoshal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9113-5167","authenticated-orcid":false,"given":"Virendra","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2026.103564_bib1","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jhep.2010.09.002","article-title":"Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue","volume":"54","author":"Boberg","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2026.103564_bib2","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.gtc.2017.01.008","article-title":"Autoimmune hepatitis overlap syndromes and liver pathology","volume":"46","author":"Czaja","year":"2017","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.jceh.2026.103564_bib3","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s12664-024-01610-5","article-title":"Frequency and spectrum of primary biliary cholangitis and its overlap with autoimmune hepatitis among patients with chronic liver disease","volume":"45","author":"Malakar","year":"2026","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.jceh.2026.103564_bib4","article-title":"Primary sclerosing cholangitis-autoimmune Hepatitis overlap syndrome: significant barriers in liver disease diagnosis and treatment experienced by the Latino community","volume":"15","author":"Guifarro","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.jceh.2026.103564_bib5","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.14309\/crj.2018.54","article-title":"Overlap syndrome between primary biliary cholangitis and primary sclerosing cholangitis","volume":"5","author":"Sundaram","year":"2018","journal-title":"ACG Case Rep J"},{"key":"10.1016\/j.jceh.2026.103564_bib6","first-page":"148","article-title":"A meta-analysis of ursodeoxycholic acid therapy versus combination therapy with corticosteroids for PBC-AIH-overlap syndrome: evidence from 97 monotherapy and 117 combinations","volume":"10","author":"Zhang","year":"2015","journal-title":"Prz Gastroenterol"},{"key":"10.1016\/j.jceh.2026.103564_bib7","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/j.1572-0241.2002.05703.x","article-title":"Overlap of autoimmune hepatitis and primary biliary cirrhosis: an evaluation of a modified scoring system","volume":"97","author":"Talwalkar","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"9 Suppl 2","key":"10.1016\/j.jceh.2026.103564_bib8","first-page":"22","article-title":"IgG4-Related disease: imitating A great imitator","volume":"74","author":"Fenderson","year":"2015","journal-title":"Hawaii J Med Public Health"},{"key":"10.1016\/j.jceh.2026.103564_bib9","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s10067-013-2326-z","article-title":"The great mimicker: IgG4-related disease","volume":"32","author":"Perez Alamino","year":"2013","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jceh.2026.103564_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2015-211893","article-title":"IgG4-related inflammatory pseudotumour mimicking a hepatic abscess impending rupture","volume":"2015","author":"Mulki","year":"2015","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jceh.2026.103564_bib11","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1016\/j.jhep.2023.09.026","article-title":"Primary sclerosing cholangitis with high immunoglobulin-G4","volume":"80","author":"Malakar","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2026.103564_bib12","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000018411","article-title":"Primary sclerosing cholangitis with increased immunoglobulin G4 levels: a case report","volume":"98","author":"Chen","year":"2019","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.jceh.2026.103564_bib13","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s00535-025-02221-3","article-title":"A clinicopathological study of IgG4-related autoimmune hepatitis and IgG4-hepatopathy","volume":"60","author":"Tanaka","year":"2025","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jceh.2026.103564_bib14","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jaut.2015.08.020","article-title":"Immunity, tolerance and autoimmunity in the liver: a comprehensive review","volume":"66","author":"Doherty","year":"2016","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jceh.2026.103564_bib15","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMra1104650","article-title":"IgG4-related disease","volume":"366","author":"Stone","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jceh.2026.103564_bib16","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/MCG.0000000000001449","article-title":"Epidemiology of Autoimmune Hepatitis (AIH) in the United States between 2014 and 2019: a Population-based National Study","volume":"55","author":"Tunio","year":"2021","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jceh.2026.103564_bib17","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jhep.2004.08.002","article-title":"Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group","volume":"41","author":"Vergani","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2026.103564_bib18","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/j.1572-0241.2007.01136.x","article-title":"Overlap of autoimmune hepatitis and primary biliary cirrhosis: long-term outcomes","volume":"102","author":"Silveira","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2026.103564_bib19","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jceh.2022.11.002","article-title":"Spectrum of autoimmune liver disease and real-world treatment experience from a tertiary care Hospital","volume":"13","author":"Taneja","year":"2023","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2026.103564_bib20","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.cgh.2011.03.019","article-title":"Prevalence of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome","volume":"9","author":"Bonder","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2026.103564_bib21","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/hep.510280210","article-title":"Frequency and nature of the variant syndromes of autoimmune liver disease","volume":"28","author":"Czaja","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2026.103564_bib22","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.3390\/jcm9051449","article-title":"Treatment of overlap syndromes in autoimmune liver disease: a systematic review and meta-analysis","volume":"9","author":"Freedman","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.jceh.2026.103564_bib23","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.510280203","article-title":"Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy","volume":"28","author":"Chazouill\u00e8res","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2026.103564_bib24","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2026.103564_bib25","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"International Autoimmune Hepatitis Group. Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2026.103564_bib26","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1053\/jhep.2002.30902","article-title":"Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid","volume":"35","author":"Joshi","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2026.103564_bib27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5387\/fms.52.71","article-title":"Clinico-laboratory characteristics of Japanese patients with primary biliary cirrhosis-autoimmune hepatitis overlap","volume":"52","author":"Saito","year":"2006","journal-title":"Fukushima J Med Sci"},{"key":"10.1016\/j.jceh.2026.103564_bib28","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1440-1746.2009.06018.x","article-title":"Overlap of primary biliary cirrhosis and autoimmune hepatitis: characteristics, therapy, and long term outcomes","volume":"25","author":"Yokokawa","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2026.103564_bib29","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/1751-2980.12196","article-title":"Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: simplified criteria may be effective in the diagnosis in Chinese patients","volume":"15","author":"Liu","year":"2014","journal-title":"J Dig Dis"},{"key":"10.1016\/j.jceh.2026.103564_bib30","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/0891693021000064272","article-title":"The hepatitic\/cholestatic \"overlap\" syndrome: an Italian experience","volume":"35","author":"Muratori","year":"2002","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jceh.2026.103564_bib31","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/j.1572-0241.2002.05703.x","article-title":"Overlap of autoimmune hepatitis and primary biliary cirrhosis: an evaluation of a modified scoring system","volume":"97","author":"Talwalkar","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2026.103564_bib32","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/j.1572-0241.2007.01136.x","article-title":"Overlap of autoimmune hepatitis and primary biliary cirrhosis: long-term outcomes","volume":"102","author":"Silveira","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2026.103564_bib33","first-page":"1009A","article-title":"Assessment of 479 patients with autoimmune liver diseases according to the IAIHG scoring system for autoimmune hepatitis does not support the contention of overlap syndromes as separate diagnostic entities: 1532","volume":"50","author":"Boberg","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2026.103564_bib34","first-page":"392","article-title":"Characteristics and inpatient outcomes of primary biliary cholangitis and autoimmune Hepatitis overlap syndrome","volume":"9","author":"Jiang","year":"2021","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.jceh.2026.103564_bib35","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s12016-015-8516-5","article-title":"The natural history and prognosis of primary biliary cirrhosis with clinical features of autoimmune hepatitis","volume":"50","author":"Yang","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jceh.2026.103564_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.jceh.2025.103146","article-title":"Dismal prognosis of primary biliary cholangitis and its overlap with autoimmune hepatitis","volume":"15","author":"Sirohi","year":"2025","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2026.103564_bib37","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/MEG.0000000000000075","article-title":"Sequential presentation of primary biliary cirrhosis and autoimmune hepatitis","volume":"26","author":"Efe","year":"2014","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2026.103564_bib38","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/hep4.1148","article-title":"New scoring classification for primary biliary cholangitis-autoimmune hepatitis overlap syndrome","volume":"2","author":"Zhang","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jceh.2026.103564_bib39","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000179","article-title":"Primary biliary cholangitis: epidemiology, prognosis, and treatment","volume":"7","author":"Trivella","year":"2023","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jceh.2026.103564_bib40","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/hep4.1148","article-title":"New scoring classification for primary biliary cholangitis-autoimmune hepatitis overlap syndrome","volume":"2","author":"Zhang","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jceh.2026.103564_bib41","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jhep.2010.09.002","article-title":"International Autoimmune Hepatitis Group. Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue","volume":"54","author":"Boberg","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2026.103564_bib42","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jhep.2005.10.017","article-title":"Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome","volume":"44","author":"Chazouill\u00e8res","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2026.103564_bib43","article-title":"Efficacy and safety of immunosuppressive therapy for PBC-AIH overlap syndrome accompanied by decompensated cirrhosis: a real-world study","volume":"2018","author":"Fan","year":"2018","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2026.103564_bib44","doi-asserted-by":"crossref","first-page":"7047","DOI":"10.3390\/jcm12227047","article-title":"Primary biliary cholangitis (PBC)-Autoimmune Hepatitis (AIH) variant syndrome: clinical features, response to therapy and long-term outcome","volume":"12","author":"Graf","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.jceh.2026.103564_bib45","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.12998\/wjcc.v8.i18.4075","article-title":"Primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome associated with inflammatory bowel disease: a case report and systematic review","volume":"8","author":"Ballotin","year":"2020","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.jceh.2026.103564_bib46","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1111\/liv.15596","article-title":"Study investigators. Setanaxib, a first-in-class selective NADPH oxidase 1\/4 inhibitor for primary biliary cholangitis: a randomized, placebo-controlled, phase 2 trial","volume":"43","author":"Invernizzi","year":"2023","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2026.103564_bib47","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/hep.22073","article-title":"Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: evaluating the role of routine magnetic resonance imaging","volume":"47","author":"Abdalian","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2026.103564_bib48","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/00042737-200406000-00012","article-title":"Frequency and predictive factors for overlap syndrome between autoimmune hepatitis and primary cholestatic liver disease","volume":"16","author":"Gheorghe","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2026.103564_bib49","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0168-8278(92)90178-R","article-title":"Frequency and significance of chronic ulcerative colitis in severe corticosteroid-treated autoimmune hepatitis","volume":"14","author":"Perdigoto","year":"1992","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2026.103564_bib50","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/hep.21405","article-title":"Sclerosing cholangitis: a focus on secondary causes","volume":"44","author":"Abdalian","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2026.103564_bib51","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2001.22131","article-title":"Autoimmune hepatitis\/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study","volume":"33","author":"Gregorio","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2026.103564_bib52","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/hep.1840360615","article-title":"Evolution of autoimmune hepatitis to primary sclerosing cholangitis: a sequential syndrome","volume":"36","author":"Abdo","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2026.103564_bib53","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2036.2008.03722.x","article-title":"Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival","volume":"28","author":"Al-Chalabi","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2026.103564_bib54","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/j.1572-0241.2005.41841.x","article-title":"Clinical course and outcome of autoimmune hepatitis\/primary sclerosing cholangitis overlap syndrome","volume":"100","author":"Floreani","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2026.103564_bib55","doi-asserted-by":"crossref","first-page":"33","DOI":"10.21037\/tgh-24-140","article-title":"Overlap syndromes in autoimmune liver disease: a review","volume":"10","author":"Sohal","year":"2025","journal-title":"Transl Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2026.103564_bib56","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.23082","article-title":"High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2026.103564_bib57","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2147\/CEG.S101440","article-title":"Autoimmune hepatitis: current challenges and future prospects","volume":"10","author":"Aizawa","year":"2017","journal-title":"Clin Exp Gastroenterol"},{"key":"10.1016\/j.jceh.2026.103564_bib58","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1080\/00365520310005172","article-title":"Long-term effect of corticosteroid treatment in primary sclerosing cholangitis patients","volume":"38","author":"Boberg","year":"2003","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jceh.2026.103564_bib59","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.3892\/etm.2016.3720","article-title":"Evaluation of the efficacy of steroid therapy on acute liver failure","volume":"12","author":"Zhao","year":"2016","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.jceh.2026.103564_bib60","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/MCG.0b013e318157c614","article-title":"Characteristics and long-term prognosis of the autoimmune hepatitis\/primary sclerosing cholangitis overlap syndrome","volume":"43","author":"L\u00fcth","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jceh.2026.103564_bib61","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1572-0241.1998.224_a.x","article-title":"Autoimmune hepatitis overlapping with primary sclerosing cholangitis in five cases","volume":"93","author":"McNair","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2026.103564_bib62","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2169\/internalmedicine.56.7633","article-title":"Two cases of primary sclerosing cholangitis overlapping with autoimmune hepatitis in adults","volume":"56","author":"Igarashi","year":"2017","journal-title":"Intern Med"},{"key":"10.1016\/j.jceh.2026.103564_bib63","doi-asserted-by":"crossref","first-page":"154","DOI":"10.5223\/pghn.2021.24.2.154","article-title":"Autoimmune sclerosing cholangitis in children: a prospective case-control Study","volume":"24","author":"Kumar","year":"2021","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"key":"10.1016\/j.jceh.2026.103564_bib64","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ejim.2008.06.004","article-title":"High prevalence of small duct primary sclerosing cholangitis among patients with overlapping autoimmune hepatitis and primary sclerosing cholangitis","volume":"20","author":"Olsson","year":"2009","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jceh.2026.103564_bib65","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2001.22131","article-title":"Autoimmune hepatitis\/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study","volume":"33","author":"Gregorio","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2026.103564_bib66","first-page":"360","article-title":"Primary biliary cirrhosis-primary sclerosing cholangitis overlap syndrome","volume":"108","author":"Rubel","year":"1984","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jceh.2026.103564_bib67","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1023\/A:1010620122567","article-title":"A case of coexisting primary biliary cirrhosis and primary sclerosing cholangitis: a new overlap of autoimmune liver diseases","volume":"46","author":"Burak","year":"2001","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2026.103564_bib68","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2147\/IJGM.S11201","article-title":"Overlap of primary biliary cirrhosis and primary sclerosing cholangitis - a rare coincidence or a new syndrome","volume":"3","author":"Jeevagan","year":"2010","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.jceh.2026.103564_bib69","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.14309\/crj.2018.54","article-title":"Overlap syndrome between primary biliary cholangitis and primary sclerosing cholangitis","volume":"5","author":"Sundaram","year":"2018","journal-title":"ACG Case Rep J"},{"key":"10.1016\/j.jceh.2026.103564_bib70","doi-asserted-by":"crossref","first-page":"336","DOI":"10.14218\/JCTH.2020.00036","article-title":"Primary sclerosing cholangitis and primary biliary cirrhosis overlap syndrome: a review","volume":"8","author":"Mago","year":"2020","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.jceh.2026.103564_bib71","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.3390\/jcm9051449","article-title":"Treatment of overlap syndromes in autoimmune liver disease: a systematic review and meta-analysis","volume":"9","author":"Freedman","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.jceh.2026.103564_bib72","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s13256-023-03908-y","article-title":"Overlap syndrome of primary biliary cholangitis and primary sclerosing cholangitis: two case reports","volume":"17","author":"Yacoub","year":"2023","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.jceh.2026.103564_bib73","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jhep.2022.05.011","article-title":"EASL Clinical Practice Guidelines on sclerosing cholangitis","volume":"77","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2026.103564_bib74","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.3748\/wjg.v26.i23.3126","article-title":"Review of primary sclerosing cholangitis with increased IgG4 levels","volume":"26","author":"Manganis","year":"2020","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2026.103564_bib75","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/MJT.0b013e3181c9dac6","article-title":"Primary sclerosing cholangitis associated with elevated immunoglobulin G4: clinical characteristics and response to therapy","volume":"18","author":"Bj\u00f6rnsson","year":"2011","journal-title":"Am J Ther"},{"key":"10.1016\/j.jceh.2026.103564_bib76","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1016\/j.jhep.2023.09.026","article-title":"Primary sclerosing cholangitis with high immunoglobulin-G4","volume":"80","author":"Malakar","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2026.103564_bib77","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3138\/canlivj-2021-0023","article-title":"Serum IgG4 cut-off of 70 mg\/dL is associated with a shorter time to cirrhosis decompensation and liver transplantation in primary sclerosing cholangitis patients","volume":"5","author":"Peerani","year":"2022","journal-title":"Can Liver J"},{"key":"10.1016\/j.jceh.2026.103564_bib78","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s00535-009-0130-y","article-title":"Primary sclerosing cholangitis with elevated serum IgG4 levels and\/or infiltration of abundant IgG4-positive plasma cells","volume":"45","author":"Koyabu","year":"2010","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jceh.2026.103564_bib79","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1111\/j.1572-0241.2006.00772.x","article-title":"Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis","volume":"101","author":"Mendes","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2026.103564_bib80","article-title":"Primary sclerosing cholangitis associated with elevated immunoglobulin-g4: a preliminary study","volume":"2012","author":"Parhizkar","year":"2012","journal-title":"ISRN Gastroenterol"},{"key":"10.1016\/j.jceh.2026.103564_bib81","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000018411","article-title":"Primary sclerosing cholangitis with increased immunoglobulin G4 levels: a case report","volume":"98","author":"Chen","year":"2019","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.jceh.2026.103564_bib82","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/iep.12076","article-title":"Frequency and significance of IgG4 immunohistochemical staining in liver explants from patients with primary sclerosing cholangitis","volume":"95","author":"Fischer","year":"2014","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.jceh.2026.103564_bib83","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/PAS.0b013e3181c6c09a","article-title":"IgG4+ plasma cell infiltrates in liver explants with primary sclerosing cholangitis","volume":"34","author":"Zhang","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jceh.2026.103564_bib84","doi-asserted-by":"crossref","first-page":"6225","DOI":"10.3748\/wjg.v12.i38.6225","article-title":"Pancreatic cancer with a high serum IgG4 concentration","volume":"12","author":"Kamisawa","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2026.103564_bib85","doi-asserted-by":"crossref","first-page":"234","DOI":"10.5009\/gnl.2013.7.2.234","article-title":"Differentiating immunoglobulin g4-related sclerosing cholangitis from hilar cholangiocarcinoma","volume":"7","author":"Tabata","year":"2013","journal-title":"Gut Liver"},{"key":"10.1016\/j.jceh.2026.103564_bib86","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3748\/wjg.v10.i3.427","article-title":"Utility of serum CA19-9 in diagnosis of cholangiocarcinoma: in comparison with CEA","volume":"10","author":"Qin","year":"2004","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.jceh.2026.103564_bib87","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s43066-023-00256-w","article-title":"Isolated variant of IgG4-sclerosing cholangitis masquerading as hilar cholangiocarcinoma \u2014 an enigmatic entity","volume":"13","author":"Ravi","year":"2023","journal-title":"Egypt Liver J"},{"key":"10.1016\/j.jceh.2026.103564_bib88","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1007\/s00261-019-01944-1","article-title":"Differentiating IgG4-related sclerosing cholangiopathy from cholangiocarcinoma using CT and MRI: experience from a tertiary referring center","volume":"44","author":"Swensson","year":"2019","journal-title":"Abdom Radiol"},{"key":"10.1016\/j.jceh.2026.103564_bib89","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5114\/reum.2022.113517","article-title":"Retrospective analysis of IgG4-related disease cases at a tertiary care centre in India","volume":"60","author":"Bhatt","year":"2022","journal-title":"Reumatologia"},{"key":"10.1016\/j.jceh.2026.103564_bib90","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.jceh.2021.11.001","article-title":"IgG4-Related sclerosing cholangitis with Cholecystitis mimicking cholangiocarcinoma: a case report","volume":"12","author":"Meena","year":"2022","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2026.103564_bib91","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1007\/s12664-020-01102-2","article-title":"IgG4-related sclerosing cholangitis- A great mimicker","volume":"39","author":"Nayak","year":"2020","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.jceh.2026.103564_bib92","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.rcl.2015.12.010","article-title":"Immunoglobulin G4-Related disease: recent advances in pathogenesis and imaging findings","volume":"54","author":"Katabathina","year":"2016","journal-title":"Radiol Clin North Am"},{"key":"10.1016\/j.jceh.2026.103564_bib93","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1148\/rg.315105735","article-title":"IgG4-related sclerosing disease: autoimmune pancreatitis and extrapancreatic manifestations","volume":"31","author":"Vlachou","year":"2011","journal-title":"Radiographics"},{"key":"10.1016\/j.jceh.2026.103564_bib94","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1053\/j.sult.2013.12.002","article-title":"IgG4-related disease in the abdomen: a great mimicker","volume":"35","author":"Al Zahrani","year":"2014","journal-title":"Semin Ultrasound CT MR"},{"key":"10.1016\/j.jceh.2026.103564_bib95","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","article-title":"Consensus statement on the pathology of IgG4-related disease","volume":"25","author":"Deshpande","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jceh.2026.103564_bib96","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13075-021-02652-2","article-title":"The risk of malignancy in patients with IgG4-related disease: a systematic review and meta-analysis","volume":"24","author":"Yu","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jceh.2026.103564_bib97","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1002\/art.39773","article-title":"Association of IgG4-Related disease with history of malignancy","volume":"68","author":"Wallace","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jceh.2026.103564_bib98","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/art.41120","article-title":"American college of Rheumatology\/European League against Rheumatism IgG4-Related disease classification criteria working group. The 2019 American college of Rheumatology\/European League against Rheumatism classification criteria for IgG4-Related disease","volume":"72","author":"Wallace","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jceh.2026.103564_bib99","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1002\/hep.31492","article-title":"IgG 4 autoimmune hepatitis presenting as idiopathic Hypereosinophilia syndrome","volume":"73","author":"Kastin","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2026.103564_bib100","article-title":"An Association between Autoimmune Hepatitis (AIH) and Immunoglobulin G4-Related disease (IgG4-RD) in a Male diagnosed with primary Sj\u00f6gren's Syndrome (SJS): a case-based review","volume":"17","author":"Bakhsh","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.jceh.2026.103564_bib101","doi-asserted-by":"crossref","DOI":"10.1177\/03000605231164003","article-title":"IgG4-related autoimmune hepatitis: a case report","volume":"51","author":"Li","year":"2023","journal-title":"J Int Med Res"},{"key":"10.1016\/j.jceh.2026.103564_bib102","article-title":"HGUV IgG4-Related Disease Working Group. Evaluation of serum IgG4 levels as a screening tool for IgG4-related disease: data from a retrospective study","volume":"21","author":"Mart\u00ednez Calabuig","year":"2025","journal-title":"Reumatol Clin (Engl Ed)"},{"key":"10.1016\/j.jceh.2026.103564_bib103","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1080\/1744666X.2017.1354698","article-title":"Diagnostic and treatment workup for IgG4-related disease","volume":"13","author":"Abraham","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jceh.2026.103564_bib104","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1007\/s10067-025-07641-3","article-title":"Risk factors for relapse of IgG4-related disease: a systematic review and meta-analysis","volume":"44","author":"Yang","year":"2025","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jceh.2026.103564_bib105","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMra1104650","article-title":"IgG4-related disease","volume":"366","author":"Stone","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jceh.2026.103564_bib106","article-title":"Current and future advances in practice: IgG4-related disease","volume":"8","author":"Wallace","year":"2024","journal-title":"Rheumatol Adv Pract"},{"key":"10.1016\/j.jceh.2026.103564_bib107","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.3906\/sag-2006-375","article-title":"IgG4-related disease: a contemporary review","volume":"50","author":"Karadeniz","year":"2020","journal-title":"Turk J Med Sci"},{"key":"10.1016\/j.jceh.2026.103564_bib108","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/hep.21700","article-title":"Immunoglobin G4-hepatopathy: association of immunoglobin G4-bearing plasma cells in liver with autoimmune pancreatitis","volume":"46","author":"Umemura","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2026.103564_bib109","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3892\/etm.2020.9476","article-title":"Levels of serum IgG subclasses in patients with liver disease: a retrospective study","volume":"21","author":"Zheng","year":"2021","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.jceh.2026.103564_bib110","doi-asserted-by":"crossref","DOI":"10.3402\/ljm.v5i0.4857","article-title":"Elevated serum immunoglobulin G levels in patients with chronic liver disease in comparison to patients with autoimmune hepatitis","volume":"5","author":"Fallatah","year":"2010","journal-title":"Libyan J Med"},{"key":"10.1016\/j.jceh.2026.103564_bib111","doi-asserted-by":"crossref","first-page":"476","DOI":"10.24976\/Discov.Med.202335177.48","article-title":"The significance of Serum IgG4\/IgG and IgG4\/IgG1 ratio in the diagnosis value of IgG4-Related diseases","volume":"35","author":"Wang","year":"2023","journal-title":"Discov Med"},{"key":"10.1016\/j.jceh.2026.103564_bib112","article-title":"Implications of gender on the outcome in patients with autoimmune hepatitis","volume":"16","author":"Malakar","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.jceh.2026.103564_bib113","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jhep.2023.09.010","article-title":"Dutch AIH Study Group; International Autoimmune Hepatitis Group. Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis","volume":"80","author":"Colapietro","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2026.103564_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.jceh.2024.101357","article-title":"Incidence of hepatocellular carcinoma in patients with autoimmune liver disease in India","volume":"14","author":"Malakar","year":"2024","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2026.103564_bib115","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1007\/s10620-025-09064-1","article-title":"Characteristics and outcomes of hepatocellular carcinoma in patients with autoimmune hepatitis","volume":"70","author":"Pasta","year":"2025","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2026.103564_bib116","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-21176-2","article-title":"Increased cancer risk in patients with IgG4-related disease in a nationwide South Korean cohort, 2012-2021","volume":"15","author":"So","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.jceh.2026.103564_bib117","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000153","article-title":"Safety, tolerability, and efficacy of maralixibat in adults with primary sclerosing cholangitis: Open-label pilot study","volume":"7","author":"Bowlus","year":"2023","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jceh.2026.103564_bib118","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1056\/NEJMoa2312100","article-title":"RESPONSE Study group. A phase 3 trial of seladelpar in primary biliary cholangitis","volume":"390","author":"Hirschfield","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jceh.2026.103564_bib119","article-title":"Current status of pharmacotherapy for primary sclerosing cholangitis","volume":"12","author":"Yang","year":"2025","journal-title":"Front Med"},{"key":"10.1016\/j.jceh.2026.103564_bib120","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa1509840","article-title":"POISE Study group. A placebo-controlled trial of obeticholic acid in primary biliary cholangitis","volume":"375","author":"Nevens","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jceh.2026.103564_bib121","doi-asserted-by":"crossref","DOI":"10.4254\/wjh.v17.i9.110264","article-title":"Difficult to treat and refractory autoimmune hepatitis: recent advances in pharmacological management","volume":"17","author":"Malakar","year":"2025","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jceh.2026.103564_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.jceh.2026.103474","article-title":"Indian National Association for Study of the Liver Guidance Document on difficult to treat autoimmune hepatitis","volume":"16","author":"Taneja","year":"2026","journal-title":"J Clin Exp Hepatol"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688326000964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688326000964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:55:40Z","timestamp":1793922940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688326000964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":122,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0973688326000964"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2026.103564","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overlap Syndromes and Associated Immunoglobulin-G4-Related Liver Diseases","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2026.103564","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103564"}}